Increased rates of intensive care unit admission in patients with Mycoplasma pneumoniae: a retrospective study T. Khoury, S. Sviri, A.A. Rmeileh, A.

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Twelve years of dengue surveillance in Belgian travellers and significant increases in the number of cases in 2010 and 2013 J. Verschueren, L. Cnops,

Impact of infection on admission and of the process of care on mortality of patients admitted to the Intensive Care Unit: the INFAUCI study J. Gonçalves-Pereira,

Familial Q fever clustering with variable manifestations imitating infectious and autoimmune disease A. Abu Rmeileh, T. Khoury, K. Meir, A. Drori, M.

C.N. van Ettekoven, D. van de Beek, M.C. Brouwer

I.J. Schalk Clinical Microbiology and Infection

Incidence and outcome of Staphylococcus aureus endocarditis—a 10-year single-centre northern European experience H. Asgeirsson, A. Thalme, M. Kristjansson,

Staphylococcus aureus colonization at ICU admission as a risk factor for developing S. aureus ICU pneumonia F.P. Paling, M. Wolkewitz, L.G.M. Bode, P.M.C.

Association of vancomycin serum concentrations with efficacy in patients with MRSA infections: a systematic review and meta-analysis T. Steinmetz, N.

Herpes zoster in non-hospitalized children

Risk factors for cryptococcal infection among patients with rheumatoid arthritis receiving different immunosuppressive medications T.-L. Liao, Y.-M.

Migrant health—a cause for concern?

Seven-day antibiotic courses have similar efficacy to prolonged courses in severe community-acquired pneumonia—a propensity-adjusted analysis G. Choudhury,

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Candida glabrata fungaemia in intensive care units

J.-P. Van geertruyden Clinical Microbiology and Infection

Impact of inadequate initial antimicrobial therapy on mortality in patients with bacteraemic cholangitis: a retrospective cohort study Y. Tagashira,

R. Cantón Clinical Microbiology and Infection

A. F. Simonetti, C. Garcia-Vidal, D. Viasus, D. García-Somoza, J

The emerging role of community sentinel surveillance in the understanding of the clinical features and epidemiology of acute Mycoplasma pneumoniae infection

A.E. Muller, U. Theuretzbacher, J.W. Mouton

Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia D. Kese, M. Maticic, M. Potocnik Clinical.

Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008–2013 L.E.B. Nabarro, R.A. Lever, M. Armstrong,

Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice? T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt

Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic A.S.

Trends in length of stay, mortality and readmission among patients with community- acquired bacteraemia M. Søgaard, R.W. Thomsen, R.B. Bang, H.C. Schønheyder,

Impact of infection on admission and of the process of care on mortality of patients admitted to the Intensive Care Unit: the INFAUCI study J. Gonçalves-Pereira,

Diagnosing infections—current and anticipated technologies for point-of-care diagnostics and home-based testing L. Bissonnette, M.G. Bergeron Clinical.

Vector control: a cornerstone in the malaria elimination campaign

Switch to oral antibiotics in the treatment of infective endocarditis is not associated with increased risk of mortality in non–severely ill patients

Sofie Arens, Jan Verhaegen, Ludo Verbist

Training for the infectious diseases speciality in Norway

G. Höffken Clinical Microbiology and Infection

Laboratory diagnosis and biosafety issues of biological warfare agents

Early invasive fungal infections and colonization in patients with cirrhosis admitted to the intensive care unit E. Theocharidou, B. Agarwal, G. Jeffrey,

Levofloxacin in the treatment of ventilator-associated pneumonia

R. Bitterman, M. Paul, D. Polak, Y. Geffen

J. Bodilsen, C. T. Brandt, A. Sharew, M. Dalager-Pedersen, T

Metagenomics and probiotics

Previously unknown species of Aspergillus

Laboratory diagnosis of Clostridium difficile disease

Familial Q fever clustering with variable manifestations imitating infectious and autoimmune disease A. Abu Rmeileh, T. Khoury, K. Meir, A. Drori, M.

T.M. File Clinical Microbiology and Infection

Systematic review of antibiotic consumption in acute care hospitals

Community-acquired pneumonia: epidemiologic and clinical consideration

Identification of risk factors associated with nosocomial infection by rotavirus P4G2, in a neonatal unit of a tertiary-care hospital R. Herruzo, F.

Effect of metronidazole versus standard care on length of stay of patients admitted with severe infectious mononucleosis: a randomized controlled trial

Evaluation of eight commercial tests for Mycoplasma pneumoniae antibodies in the absence of acute infection R. Nir-Paz, A. Michael-Gayego, M. Ron, C.

Vaccinations against respiratory tract infections at Hajj

Clinical infection services—the Leiden experience

Increasing numbers of hospitalizations and deaths with mention of Clostridium difficile infection, north-eastern Italy, 2008–2013 U. Fedeli, E. Schievano,

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

A. van Samkar, M. C. Brouwer, Y. Pannekoek, A. van der Ende, D

Survival of rhinoviruses on human fingers

Utility of C-reactive protein in assessing the disease severity and complications of community-acquired pneumonia U. Hohenthal, S. Hurme, H. Helenius,

The atypical pneumonias: clinical diagnosis and importance

J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin

Virology: a scientific discipline facing new challenges

Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group† H. Goossens Clinical.

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

Great oaks from little acorns grow—21 years of CMI

Impact of antibiotic restrictions: the patient's perspective

Staphylococcus aureus colonization at ICU admission as a risk factor for developing S. aureus ICU pneumonia F.P. Paling, M. Wolkewitz, L.G.M. Bode, P.M.C.

CMI readers' survey Clinical Microbiology and Infection

Rajko Saletinger, Mario Poljak, Franc Strle

The future of diagnostic bacteriology

Presentation transcript:

Increased rates of intensive care unit admission in patients with Mycoplasma pneumoniae: a retrospective study T. Khoury, S. Sviri, A.A. Rmeileh, A. Nubani, A. Abutbul, S. Hoss, P.V. van Heerden, A.E. Bayya, C. Hidalgo-Grass, A.E. Moses, R. Nir- Paz Clinical Microbiology and Infection Volume 22, Issue 8, Pages 711-714 (August 2016) DOI: 10.1016/j.cmi.2016.05.028 Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 1 (a) Age-related admission to intensive care unit (ICU) in all Mycoplasma pneumoniae cases. ICU admission was 4.6% in patients ≤18 years old; rose to 18.4% in the 19–40 age group and 18.9% in the 41–65 age group; and increased to 38.8% for those aged >65 years. (b) Age-related mortality among ICU admitted M. pneumoniae–infected patients. Mortality was commonest among patients >65 years of age, reaching 46.4% Clinical Microbiology and Infection 2016 22, 711-714DOI: (10.1016/j.cmi.2016.05.028) Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions